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Tyrosine kinase receptor RON functions downstream of the erythropoietin
receptor to induce expansion of erythroid progenitors
Emile van den Akker, Thamar van Dijk, Martine Parren-van Amelsvoort, Katja S. Grossmann, Ute Schaeper, Kenya Toney-Earley,
Susan E. Waltz, Bob Lo¨wenberg, and Marieke von Lindern
Erythropoietin (EPO) is required for cell
survival during differentiation and for pro-
genitor expansion during stress erythro-
poiesis. Although signaling pathways may
couple directly to docking sites on the
EPO receptor (EpoR), additional docking
molecules expand the signaling platform
of the receptor. We studied the roles of
the docking molecules Grb2-associated
binder-1 (Gab1) and Gab2 in EPO-in-
duced signal transduction and erythropoi-
esis. Inhibitors of phosphatidylinositide
3-kinase and Src kinases suppressed
EPO-dependent phosphorylation of Gab2.
In contrast, Gab1 activation depends on
recruitment and phosphorylation by the
tyrosine kinase receptor RON, with which
it is constitutively associated. RON activa-
tion induces the phosphorylation of Gab1,
mitogen-activated protein kinase (MAPK),
and protein kinase B (PKB) but not of
signal transducer and activator of tran-
scription 5 (Stat5). RON activation was
sufficient to replace EPO in progenitor
expansion but not in differentiation. In
conclusion, we elucidated a novel mecha-
nism specifically involved in the expan-
sion of erythroblasts involving RON as a
downstream target of the EpoR. (Blood.
2004;103:4457-4465)
© 2004 by The American Society of Hematology
Introduction
Erythropoietin (EPO) is required for the survival, proliferation, and
differentiation of erythroblasts. It acts with other growth factors
and hormones to balance the expansion and terminal differentiation
of the erythroid compartment. For instance, stem cell factor (SCF),
a ligand of c-Kit, cooperates with EPO to delay differentiation and
to enhance progenitor numbers.1,2 The EPO receptor (EpoR) is a
homodimer constitutively associated with Janus tyrosine kinase 2
(Jak2). Ligand binding induces a conformational change of the
EpoR dimer,3,4 resulting in the activation of Jak2, the phosphoryla-
tion of the EpoR on 8 tyrosine residues, and the recruitment of
multiple signaling molecules.5-7 Mice deficient in EPO, EpoR, or
Jak2 lack definitive erythropoiesis.8-11 Although this demonstrates a
crucial role for EPO-induced Jak2 activation in erythropoiesis, the
contribution of individual downstream signaling pathways to
erythroblast proliferation, differentiation, and survival is less clear.
Notably, mice expressing a truncated EpoR, lacking all tyrosine
residues, are not anemic.12 This may implicate that additional
proteins, such as docking molecules, can form a complex with the
EpoR to create a signaling platform with sufficient specificity to
regulate the balance of erythroid expansion and differentiation.
Candidates for this function are the Grb2-associated binder
(Gab) family members. At present, 3 Gab family members have
been identified—Gab1, Gab2, and Gab3.13,14 Gab1 is ubiquitously
expressed, whereas Gab2 and Gab3 expression are tissue specific.
In the hematopoietic system, Gab3 is expressed in B cells and T
cells and in the myeloid compartment, whereas Gab2 is expressed
in all hematopoietic cells except T cells. Gab1 deficiency is
embryonically lethal because of placental defects; Gab1/
embryos are also characterized by reduced liver size and migration
defects of muscle precursor cells.15,16 In contrast, Gab2 deficiency
results only in mild defects in mast cell and macrophage re-
sponses,17,18 and Gab3-deficient mice show normal hematopoi-
esis.19 Gab2 and Gab3 lack the c-Met binding sequence (MBS) of
Gab1 and, therefore, may not complement Gab1 in c-Met signal-
ing. Furthermore, the high homology between family members
suggests that complementation by the ubiquitously expressed Gab1
may occur in Gab2/3 knockouts. On tyrosine phosphorylation, Gab
proteins recruit signaling intermediates, among them Shc (Src
homology–containing protein), Shp2 (Src-homology domain con-
taining phosphatase), p85 subunit of phosphatidylinositol 3-kinase
(PI3K), and phospholipase C 1/2 (PLC1/2).20,21 Gab1 is phosphor-
ylated after the stimulation of the EpoR.22 However, it has not been
determined whether Jak2 is directly involved in this process or
whether kinases other than Jak2 could be required for Gab1
phosphorylation.
Gab1 is a direct substrate of the receptor tyrosine kinase
c-Met.23 RON (Stk), a close homologue of c-Met, is expressed in
erythroblasts as full length (RONfl) and short form (RONsf);
RONsf lacks the extracellular domain. Notably, susceptibility for
Friend virus–induced murine erythroid leukemia is fully dependent
on RONsf expression.24 Friend virus induces EPO-independent
erythroblast growth through a mechanism that has not been
completely determined but that involves binding of the viral
protein gp55 to EpoR and RONsf.25,26 RON and c-Met are highly
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homologous at the multiple docking site with which Gab1 interacts,
suggesting a role for Gab1 in RON signaling. RON activation
results in activation of PI3K and of the mitogen-activated protein
kinase (MAPK) route,27,28 pathways implicated in the expansion of
erythroblasts29 and downstream effectors of Gab proteins.22
We examined how Gab proteins function in EPO-induced
signaling. We show that Gab2 is phosphorylated in response to
EPO by a mechanism requiring a Src-like kinase and PI3K. In
contrast, EPO-induced Gab1 phosphorylation occurs through a
mechanism involving EPO-dependent activation of RON. Direct
activation of RON, using a TrkA-RON fusion receptor, is sufficient
to substitute EPO in progenitor expansion, but it cannot substitute
for EPO to sustain differentiation to mature erythrocytes.
Materials and methods
Antibodies and growth factors
Rabbit antisera recognizing Jak2 or Gab1 and a mouse monoclonal
antibody recognizing phospho-signal transducer and activator of transduc-
tion 5 (Stat5) (Y694-Stat5A/Y699-Stat5B; 05-495) were obtained from
Upstate Biotechnology (Lake Placid, NY); rabbit antisera recognizing the
mouse EpoR, RON, TrkA, or p44/p42 Erk1/2 and the antiphosphotyrosine
mouse monoclonal antibody PY99 were from Santa Cruz Biotechnology
(Santa Cruz, CA; sc-697, sc-322, sc-14024, sc-94, sc-7020, respectively);
and rabbit antisera recognizing phospho-protein kinase B (PKB) (Ser473;
9271) and mouse monoclonal antibodies recognizing phospho-p44/p42
Erk1/2 (Thr202/Tyr204; 9101) were from Cell Signaling Technology
(Beverly, MA). Rabbit antiserum recognizing Gab2 was a kind gift from Dr
T. Hirano (Osaka University, Japan). Human macrophage-stimulating
protein (MSP) was obtained from R&D Systems (Minneapolis, MN),
recombinant human EPO was a gift from Ortho-Biotech (Tilburg, The
Netherlands), dexamethasone (Dex) was purchased from Sigma (Zwijndrecht,
The Netherlands), and SCF was obtained from the supernatant of producer
Chinese hamster ovary (CHO) cells.
Plasmids and oligonucleotides
The complete open reading frame of RONfl (a kind gift of Dr Breathnach,
Institut de Biologie-CHR, Nantes, France), Tec, Jak2, Lyn, EpoR, Gab1,
and Gab2 were cloned into the mammalian expression vector pSG5
(Stratagene, La Jolla, CA) and the retroviral vector pBabe-puro when
indicated. The kinase dead form of RON, K1114M, was generated using the
Quickchange Site-directed Mutagenesis Kit (Stratagene) with the oligonu-
cleotides 5-CCA ATG TGC CAT CGA TTC ACT AAG TCG CA-3 and
5-GCT CTC CAG CGC CGT CCA CTT CAC A-3. To construct
TrkA-RON, the extracellular domain of the TrkA receptor was expanded
using polymerase chain reaction (PCR) (from TrkA-Met30) using forward
primer 5-GCG AAT TCA TGC TGC GAG GCG GAC GGC GC-3 and
reverse primer 5-GCG ATA TCC TTC TTC TCC ACC GGG TCT CC-3,
after which the fragment was cut with EcoRI and EcoRV. The RON
transmembrane/intracellular domain PCR product was amplified using
forward primer 5-GCG ATA TCC TCC TTG GTA TCC TGC TGC CT-3
and reverse primer 5-CGC TCG AGC TAA GCA GGT CCA GCC CAA
GA-3 and was digested with EcoRV and XhoI. Both fragments were
simultaneously ligated into the EcoRI/SalI site of the retroviral vector
pBabe-puro, creating the TrkA-RON fusion receptor (Figure 5A). The
prey plasmids VP16-Gab1, VP16-Gab2, and VP16-Gab2MBS have
been described.23
Yeast 2-hybrid analysis
The yeast strain L40 was used for the yeast-2-hybrid (Y2H) transformation
assays.31 It contains his3 and lacZ as reporter genes. Bait plasmids
BTM-RON and BTM-RONkd code for the kinase-active and kinase-
inactive cytoplasmic portions of the human receptor tyrosine kinase RON,
respectively. This cytoplasmic portion was fused to the LexA DNA-binding
and dimerization domain. Sequences encoding amino acids 983 to 1400 of
wild-type (wt) RON or RON K1114M were amplified by PCR (using
5-GGA ATT CCG GAG GAA GCA GCT AGT TCT TCC-3 and 5-AAA
AAA GTC GAC TCA AGT GGG CCG AGG AGG CTC-3) and were
cloned into pBMT as EcoRI/SalI fragments. The -galactosidase assay
measures lacZ reporter gene activity to quantify the interactions between
bait and prey proteins. Yeast was grown in liquid culture, and optical
density was measured at   600 nm, pelleted, and cracked open using a
freeze-thaw technique in liquid nitrogen. -galactosidase activity was
determined colorimetrically using the compound ONPG (o-nitrophenyl--
D-galactopyranoside) as a substrate (  420 nm). The following formula
was used to calculate relative -galactosidase activity: 1000  OD 420/
(t  V  OD 600), where OD indicates optical density, t indicates time
(minute), and V indicates volume (mL).
Cell lines, primary cells, transfections, and viral transductions
COS, HEK293, and ecotropic Phoenix (	E) cells were maintained in
Dulbecco modified Eagle medium (DMEM; Life Technologies, Paisley,
United Kingdom) supplemented with 10% fetal calf serum (FCS; Life
Technologies). For COS and HEK293 transfection experiments, 1 million
cells were seeded in 60-mm2 dishes and, after 3 to 4 hours (COS cells) and
24 hours (293 cells), were transfected with 12 
g DNA, as previously
described.32 After 24 hours the cells were washed once with phosphate-
buffered saline (PBS), and new medium was added. Cells were harvested 48
hours after transfection. Primary fetal liver erythroblasts and the murine
erythroblast cell line R1 (generated as described before)29 were cultured in
StemPro-34 medium (Life Technologies) supplemented with EPO (0.5
U/mL), SCF (100 ng/mL), and Dex (50 
M). Cell cultures were maintained
at 1.5 to 3  106 cells/mL. Viral transduction of the erythroblast cell line R1
was performed as described.33 To obtain single cell–derived clones, cells
were seeded in semisolid Stempro-34 medium supplemented with EPO,
SCF, and Dex, as described, plus puromycin (2 
g/mL). To induce
differentiation, erythroid cells were washed 2 times with PBS and were
reseeded in StemPro-34 medium supplemented with 5 U/mL EPO and 0.5
mg/mL iron-saturated human transferrin (Intergen, Purchase, NY). During
differentiation, cells were kept at 2 to 5  106 cells/mL.
Hemoglobin content determination and cell morphology
To measure the hemoglobin content in cells, 3 50-
L aliquots of the
cultures were taken and processed for photometric determination of
hemoglobin, as described.33 To analyze cell morphology, 50-
L samples
were taken from culture, cytocentrifuged onto slides, and stained with
histologic dyes and neutral benzidine for hemoglobin.34 Images were taken
with a charge-coupled device (CCD) camera and were processed using
Adobe Photoshop.
Immunoprecipitations and Western blotting
Primary erythroid fetal liver cells and the erythroblast cell line R1 were
growth factor deprived for 4 hours in plain Iscove modified Dulbecco
medium (IMDM; Life Technology), and HEK293 cells were serum
deprived for 24 hours in plain DMEM. Erythroblasts (40-80  106/mL)
were stimulated at 37°C with SCF (1 
g/mL; 5 minutes), EPO (5 U/mL; 10
minutes), MSP (100 ng/mL; 10 minutes), or NGF (100 ng/mL; 10 minutes),
as indicated, and HEK293 cells and COS cells were stimulated for 10
minutes with 100 ng/mL MSP or EPO (5 U/mL). Reactions were stopped
with excess ice-cold PBS. Cells were washed twice with ice-cold PBS,
lysed in ice-cold lysis buffer,35 incubated on ice for 10 minutes, frozen in
nitrogen, and stored at 80°C until use. Lysates were thawed on ice and
cleared by centrifugation at 4°C at 15 000 rpm. Immunoprecipitation,
sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE),
and Western blot analysis were performed as described previously.35
Membranes were stripped in 63 mM Tris-HCl pH 6.1, 2% SDS, and 100
mM -mercaptoethanol for 30 minutes at 50°C, after which they were
reblocked and restained.
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Results
EPO-induced phosphorylation of Gab1 and Gab2 is
differentially dependent on PI3K activity
In accordance with previous observations, Gab1 and Gab2 are
tyrosine phosphorylated in response to EPO in the erythroid cell
line R1 (Figure 1A).20,21 Several phosphorylated proteins coimmu-
noprecipitated with Gab1 and Gab2. Reprobing the same blots with
specific antibodies identified the adaptor protein Shc (50 kDa) and
the tyrosine phosphatase Shp2 (75 kDa; Figure 1A). EPO-induced
Gab1 and Gab2 phosphorylation were also detected in erythro-
blasts cultured from primary bone marrow and from fetal liver
(data not shown). Because an N-terminal pleckstrin homology (PH)
domain characterizes Gab proteins, their recruitment and phosphor-
ylation are expected to be dependent on PI3K activity. R1 cells
were factor-deprived and restimulated with EPO in the presence of
increasing concentrations of the PI3K inhibitor LY294002 (7.5-45

M; Figure 1A). Although EPO-induced Gab2 phosphorylation
was dose-dependently inhibited in the presence of LY294002,
Gab1 phosphorylation was, to a large extent ( 40%), resistant to
inhibition by LY294002 (Figure 1A-B). Similarly, the coimmuno-
precipitation of Shc with Gab2, but not with Gab1, was fully
inhibited by LY294002. The level of phosphorylated Shp2 detected
in Gab1 immunoprecipitates was reduced at increasing concentra-
tions of LY294002, which might have been because of the
phosphorylation of Shp2 by LY294002-sensitive kinases. Together
the data suggest that alternative mechanisms for Gab1 and Gab2
phosphorylation may exist.
Gab1 is a good substrate of RON and Lyn, Gab2 of Lyn only
To investigate what kinases are involved in the phosphorylation of
Gab1 and Gab2, we expressed Gab1 or Gab2 in COS cells with
various kinases involved in EpoR and c-Kit signaling, among them
Jak2, Tec, Btk, Lyn, RONfl, and RONsf. Expression of the various
kinases was checked on a phosphotyrosine Western blot (Figure
2A). Next, Gab1 and Gab2 were immunoprecipitated and analyzed
for phosphorylation (Figure 2B-C). Expression of the Src kinase
family member Lyn resulted in the phosphorylation of Gab1 and
Gab2. In addition, Gab1, but not Gab2, appeared to be a good
substrate for RON. Moreover, RONfl and RONsf coimmunoprecipi-
tated with Gab1, but not with Gab2. Jak2, Tec, and Btk did not
efficiently phosphorylate Gab1 or Gab2, though the absence of Gab
phosphorylation by Tec might have been the result of its low
autophosphorylation signal (Figure 2A). To investigate whether Src
kinases are required for Gab1/2 phosphorylation in erythroblasts,
we analyzed EPO-induced phosphorylation of Gab1 and Gab2 in
immortal (R1) and primary erythroblasts (cultured for 5 days from
fetal livers) preincubated with the Src kinase inhibitor PP2 (5 
M).
EPO-induced Gab1 phosphorylation appeared resistant to the Src
kinase inhibitor PP2, whereas EPO-induced Gab2 phosphorylation
and coimmunoprecipitation of Gab2-associated proteins were
completely inhibited (Figure 2D-E).
The insensitivity of EPO-induced Gab1 phosphorylation to
inhibitors of Src kinases and PI3K may result from the observed
association of Gab1 and RON and the phosphorylation of Gab1 by
RON. To investigate whether Gab1 can interact with RON as it
does with the RON family member c-MET, we carried out Y2H
interaction experiments.23 The cytoplasmic domain of kinase-
active RON or kinase-dead RON receptor (RONkd; K1114M) was
expressed as bait and full-size Gab1 or Gab2 as prey vector. Gab1,
but not Gab2, associated efficiently with activated RON, whereas
both Gab1 and Gab2 bound the known interaction partner Grb2
(Figure 2F). The association with RON in yeast was phosphoryla-
tion-dependent; we did not detect the binding with kinase-dead
bait. A 13-amino acid MBS is responsible for the direct association
of Gab1 with the c-Met receptor.23 A Gab2 construct in which the
MBS of Gab1 is inserted interacted efficiently with RON, indicat-
ing that the direct association of Gab1 with activated RON is
mediated through the MBS of Gab1. In conclusion, RON is able to
phosphorylate Gab1, whereas Src-like kinases are able to phosphor-
ylate Gab1 and Gab2. The ability of RON to recruit and phosphor-
ylate Gab1 may be responsible for PI3K and Src family–
independent phosphorylation of Gab1 in erythroblasts.
EPO induces tyrosine phosphorylation of RON
If RON mediates EPO-induced Gab1 phosphorylation, it is ex-
pected to be a downstream target of EPO signaling. The natural
Figure 1. EPO-induced phosphorylation of Gab2, but not Gab1, is dependent on
PI3K activity. (A) Erythroblast cell line R1 was factor deprived (4 hours), left
untreated (lane 1), or restimulated with EPO (5 U/mL; 10 minutes) in the presence of
increasing amounts of the PI3K inhibitor LY294002. Gab1 and Gab2 were immuno-
precipitated from cell lysates and analyzed for tyrosine phosphorylation on Western
blot. The same blots were stained with anti-Gab1 and anti-Gab2 to control equal
loading. Coimmunoprecipitated Shp2 and Shc were detected by specific antibodies.
Size markers (kDa) and coimmunoprecipitating proteins are indicated next to the
panels. (B) Tyrosine phosphorylation of Gab1 and Gab2 in the presence of increasing
concentrations of LY294002 was quantified by densitometric analysis as shown in
panel A. Intensity in absence of LY294002 was set at 100%.
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ligand for RON is MSP, though ligand-independent phosphoryla-
tion and activation have also been described (see “Discussion”). To
investigate factor-dependent RON tyrosine phosphorylation, R1
erythroblasts were factor-deprived and stimulated with MSP or
EPO. RON immunoprecipitates were assayed for tyrosine-
phosphorylated proteins. MSP failed to induce tyrosine phosphory-
lation of RON (Figure 3A). In contrast, RON was tyrosine
phosphorylated in response to EPO. Tyrosine-phosphorylated pro-
teins of 100 kDa, 70 kDa, and 50 kDa were detected in the RON
immunoprecipitates from EPO-stimulated cells. The lack of re-
sponse to MSP was not attributed to an inactive batch of MSP
because MSP induced the phosphorylation of transiently expressed
RONfl in HEK293 cells (Figure 3B). Note that EPO did not induce
RON phosphorylation in cells lacking endogenous EpoR.
To analyze factor-dependent recruitment of Gab1 to RON in
erythroblasts, Gab1 was immunoprecipitated from EPO-stimulated
and nonstimulated lysates of primary and immortalized (R1)
erythroblasts (Figure 3C-D). In contrast to the data obtained by
Y2H, RON coimmunoprecipitated with Gab1 in all conditions
tested (see “Discussion”). We were unable to detect Gab1 in RON
immunoprecipitates because a strong background band interfered
with specific detection of Gab1 (data not shown). To check whether
Gab1 is dependent on RON for its phosphorylation, we analyzed
EPO-dependent Gab1 and Gab2 phosphorylation in erythroblasts
expanded from embryonic day 13.5 (E13.5) fetal livers of mice in
which the intracellular portion of RON, including the kinase
domain and Gab1-docking domain, was deleted (RON TK/).36
Although Gab1 is phosphorylated in response to EPO in wt
erythroblasts, it is not phosphorylated in RON TK/ cells,
despite the fact that Gab1 expression in RON TK/ cells is
comparable to that in wt cells (Figure 3E). In contrast, EPO-
dependent phosphorylation of Gab2 is increased in RON TK/
erythroblasts compared with wt cells (Figure 3F). In conclusion,
the tyrosine kinase receptor RON is a target of EpoR signaling and
is the exclusive kinase required for the recruitment and phosphory-
lation of Gab1.
RON is phosphorylated by Jak2 and associates with the EpoR
The EpoR activates several tyrosine kinases, including Jak2 and
Lyn.37,38 To identify kinases with the potential to tyrosine phosphor-
ylate RON, we expressed RONkd in COS cells, together with the
tyrosine kinases Lyn, Tec, and Jak2. Lyn, Tec, and Jak2 all
coimmunoprecipitated with wt RONfl (Figure 4A), and RON-
specific antibodies did not immunoprecipitate these kinases
from COS cells when RON was not coexpressed (data not
shown). Kinase-dead RONfl was only phosphorylated in the
presence of Jak2 (Figure 4B). Taking all other experiments into
account, this suggests, but does not necessarily imply, that Jak2
also activates RON.
It has been shown that RONsf associates with the EpoR, but no
data were published for RONfl.39 Therefore, EpoR, RONfl, and
Jak2 were expressed in COS cells, which were stimulated with
EPO before harvesting. Both Jak2 and RON coimmunoprecipitated
Figure 2. Distinct regulation of Gab1 and Gab2 tyrosine phosphorylation. (A-C) COS cells were transfected with pSG5-based expression constructs encoding Gab1,
Gab2, and various kinases, as indicated. After 48 hours, cells were harvested. (A) Phosphorylation status of transfected kinases was detected on Western blots using
antiphosphotyrosine antibodies (PY99). Similarly, Gab1 (B) and Gab2 (C) immunoprecipitates were analyzed for tyrosine phosphorylation. Arrows indicate the positions of
Gab1, Gab2, RONsf, and RONfl. Size markers are indicated in kDa. Blots were restained with anti-Gab1 or anti-Gab2, as indicated. (D-E) R1 erythroblasts (D) and fetal
liver-derived erythroblasts (E) were factor deprived for 4 hours in the absence or presence of the Src kinase family inhibitor PP2 (5 
M), as indicated. Cells were left
unstimulated or were stimulated with EPO (5 U/mL; 10 minutes). EPO-induced Gab1 or Gab2 phosphorylation was assayed on immunoblots using PY99, and equal loading
was controlled by staining with anti-Gab1 or anti-Gab2. Size markers are indicated in kDa. (F) Gab 1 associated directly with RON in Y2H assays. Gab proteins were
coexpressed with RON, RONkd, and Grb2 in the yeast reporter strain L40. Gab2MBS encodes Gab2 protein with an insertion of MBS. Associations were quantified by
-galactosidase liquid assay.
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with EpoR in the presence and the absence of EPO stimulation
(Figure 4C; data not shown). However, Jak2, but not RON, induced
EPO-dependent EpoR phosphorylation. Coexpression of RON and
Jak2 did not affect the phosphorylation of EpoR by Jak2 or the
association of RON and Jak2 with the EpoR.
Activation of RON results in phosphorylation of Gab1, PKB,
and Erk1/2, but not Stat5
We next examined the role of RON and Gab1 in the expansion,
differentiation, and survival of erythroblasts. Given that RON was
not activated by MSP in erythroid cells, we constructed a nerve
growth factor (NGF)–responsive TrkA-RON fusion receptor (Fig-
ure 5A) that was expressed in immortalized erythroblasts (R1).
TrkA-RON was equally well expressed in a large number of clones,
and NGF stimulation resulted in the phosphorylation of TrkA-RON
(data not shown).
Although Gab1, but not Gab2, was a substrate of RON in COS
cells, NGF-induced activation of TrkA-RON in R1 cells resulted in
Gab1 and Gab2 tyrosine phosphorylation. NGF did not induce
Gab1/2 phosphorylation in control clones, but EPO induced Gab1
and Gab2 phosphorylation in all cultures (Figure 5B). This implies
that, in the natural context of erythroblasts, Gab1 and Gab2 are
downstream targets of RON signaling. Because RON was able to
associate with Lyn (Figure 4A-B) and because the inhibition of Src
kinases abrogated EPO-induced Gab2 phosphorylation in erythro-
blasts (Figure 2D-E), it is possible that RON-mediated Gab2
phosphorylation occurs through Lyn. The RON homologue c-Met
was similarly shown to associate with Lyn on activation by NGF.40
Both NGF and EPO induced the phosphorylation and association
of 120- and 150-kDa unknown proteins with Gab1 in TrkA-RON–
expressing cells (Figure 5B). Finally, we tested whether the
activation of TrkA-RON induced some of the major signaling
pathways activated by EpoR. NGF, like EPO, induced the phosphor-
ylation of Erk1/2 and PKB. In contrast, NGF failed to induce Stat5
(Figure 5C) or Stat3 tyrosine phosphorylation (data not shown).
RON activation can substitute EPO in inducing
progenitor expansion
EPO, SCF, and Dex are required for erythroblast expansion,
including the erythroblast cell line R1, whereas EPO induces
differentiation into mature erythrocytes in the absence of SCF and
Dex (Figure 6A). Erythroblast exposure to SCF and Dex in the
absence of EPO cannot sustain renewal divisions.29 To examine the
role of RON signaling in EPO-dependent expansion and differentia-
tion of erythroblasts, TrkA-RON–expressing erythroblasts and
control erythroblasts were seeded in medium supplemented with
EPO, SCF, and Dex, in medium supplemented with NGF, SCF, and
Dex, or in medium without factors. Vector-transduced control
clones cultured in the presence of NGF, SCF, and Dex did not
proliferate but became pyknotic, indicating that NGF does not exert
any biologic effect on control erythroblasts (Figure 6B-C). In
contrast, TrkA-RON–expressing erythroblasts proliferated equally
well in the presence of NGF, SCF, and Dex and in the presence of
EPO, SCF, and Dex (Figure 6B), and they retained a blast
morphology under each condition (Figure 6C). Both the TrkA-
RON and the empty vector clones are still factor dependent; the
absence of factors resulted in no growth and in rapid cell death
(Figure 6B-C). This showed that RON activation can replace the
ligand-activated EpoR in its function to enhance the expansion of
erythroblasts. Although we showed that RON can associate with
Figure 4. RON forms a complex with the EpoR and is a substrate
of Jak2. (A-B) COS cells were transfected with pSG5-based expres-
sion constructs encoding RONwt (A) or RONkd (B), together with Lyn,
Tec, and Jak2. Cells were harvested without factor stimulation. (C)
COS cells were transfected with RONwt, together with EpoR and
Jak2, and were stimulated with EPO (5 U/mL) 10 minutes before cell
harvest. (A-C) Two days after transfection, COS cells were lysed, and
RON (A-B) or EpoR (C) was immunoprecipitated. Immunoprecipitated
proteins were subjected to SDS-PAGE and immunoblotting. Size
markers are indicated in kDa. Upper panels represent blots stained
with antiphosphotyrosine antibodies (PY99), and lower panels repre-
sent blots stained with anti-RON, anti-EpoR, or both, when appropri-
ate.Arrows indicate the positions of the expressed proteins.
Figure 3. Gab1 is an interaction partner and a substrate of RON in erythro-
blasts. (A) Immortalized (R1) and primary fetal liver–derived erythroblasts were
factor deprived and subsequently stimulated with EPO (5 U/mL; 10 minutes) or MSP
(100 ng/mL; 10 minutes). Anti-RON immunoprecipitates were analyzed for proteins
phosphorylated on tyrosine using monoclonal PY99. Blots were stained with
anti-RON to control phosphorylated protein comigration with RON and to control
loading. Arrows indicate the position of RON and the position plus molecular weight of
phosphorylated coimmunoprecipitated proteins. Anti-RON did not stain a 150-kDa
protein in immunoprecipitates obtained with unrelated antibodies (eg, anti-Btk; data
not shown), indicating that the 150-kDa band is specific for the anti-RON immunopre-
cipitate. (B) HEK293 cells were mock transfected or transfected with pSG5-RONfl,
serum deprived, and stimulated with EPO (5 U/mL; 10 minutes) or MSP (100 ng/mL;
10 minutes). Anti-RON immunoprecipitates were tested for RON phosphorylation, as
described for panel A. (C-D) Erythroblast cell line R1 (C) and fetal liver–derived
erythroblasts (D) were factor deprived and restimulated with EPO (5 U/mL; 10
minutes). Gab1 was immunoprecipitated, and blots were stained with antiphosphoty-
rosine antibodies (PY99) and antibodies against Gab1 and RON, as indicated. (E-F)
Fetal liver–derived erythroblasts derived from RON TK/ embryos and wt litter-
mates were factor deprived and restimulated with EPO (5 U/mL; 10 minutes).
Western blots containing Gab1 and Gab2 immunoprecipitates were stained with
antiphosphotyrosine and with anti-Gab1 or anti-Gab2 to check equal loading.
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EpoR (Figure 4), the EPO-independent proliferation of TrkA-RON–
expressing progenitors is not caused by NGF-induced phosphoryla-
tion of EpoR (Figure 6D).
RON activation delays EPO-induced differentiation
We next examined whether RON activation is able to support
erythroid differentiation. TrkA-RON–expressing and control clones
were seeded in differentiation medium without factors, supple-
mented with EPO (2 U/mL) or with NGF (100 ng/mL). Cumulative
cell number, cell size, hemoglobin accumulation, and cell morphol-
ogy were determined at regular intervals. Although EPO induced
transient proliferation, gradual decreases in cell size, and accumula-
tions of hemoglobin, NGF completely failed to do any of these
either in the control or in the TrkA-RON–expressing cells (Figure
7A-C). TrkA-RON–expressing cells rapidly died in the presence
and in the absence of NGF (data not shown). Thus, RON activation
could not replace EPO in differentiation. Given that TrkA-RON
activation can replace EPO during self-renewal, we examined how
the proliferation signals from TrkA-RON compared with EPO-
induced differentiation signals. We cultured TrkA-RON clones
with EPO or with EPO and NGF and assayed proliferation, cell
size, and hemoglobinization. Exposing TrkA-RON–expressing
erythroblasts to NGF and EPO caused prolonged proliferation,
delayed hemoglobinization, and sustained blastoid cell size during
the first 4 days of culture (Figure 7D-F). The data indicate that
signals from TrkA-RON dominantly promoted erythroid renewal
division but failed to sustain erythroblast differentiation (Figure
7G). Finally, we examined whether the tyrosine kinase activity of
RON and the activation of Gab1 are essential for the expansion of
erythroblasts. Erythroid progenitors were derived from E13.5 fetal
livers of RON TK/36 and Gab1-deficient16 mouse embryos and
control littermates and were seeded in medium supplemented with
EPO, SCF, and Dex. All cultures expanded with similar kinetics for
14 days, as previously shown for primary cells.29,41 Progenitors
cultured for 5 days from RON TK/ livers and wt littermates, or
from Gab-deficient livers and wt littermates, were seeded in
differentiation conditions (5 U/mL EPO; no SCF or Dex), and cell
number, cell size, and hemoglobin accumulation were determined
at 8-hour intervals. In all cultures, cells were enucleated in 48
hours, as previously described,41 and no differences in cell
proliferation, cell size, or hemoglobin accumulation were detected
(data not shown). Thus, RON and Gab1 activation seemed not to be
crucial, which may be explained by the increased EPO-induced
Gab2 phosphorylation observed in these cells (Figure 3F and data
not shown).
Discussion
In the present study, we identified Gab1 and Gab2 as important
players in EPO-induced progenitor-expansion signaling, each re-
cruited and phosphorylated by a distinct mechanism. Recruitment
and phosphorylation of Gab2 were dependent on the activation of
PI3K and Src-like kinase, respectively, whereas Gab1 phosphoryla-
tion was fully dependent on the tyrosine kinase receptor RON,
which appeared to be a specific target of EpoR signaling.
Gab docking proteins are activated by distinct mechanisms
As can be expected from proteins carrying a PH domain, Gab2 is
recruited to the phosphatidylinositol-3,4,5-triphosphate (PIP3)–
rich pockets in the membrane around the activated receptor. Gab2
can interact with Grb2, which in turn associates with tyrosine
residue Y464 of the EpoR.42 However, the requirement for Grb2 to
recruit Gab2 to the EpoR has not been analyzed. Possibly this
interaction facilitates the localization of Gab2 close to Lyn
(reported to associate with tyrosine residues 464 and 479 of the
EpoR43). The observation that the Src kinase inhibitor PP2
suppresses Gab2 phosphorylation and the reported role for Lyn in
EpoR signaling44,45 make Lyn a likely kinase responsible for Gab2
phosphorylation. In contrast, Gab1 phosphorylation was only
Figure 5. Activation of TrkA-RON induces phosphorylation of multiple down-
stream targets. (A) Representation of the TrkA-RON fusion protein transduced into
erythroblasts. The extracellular portion of TrkA (italicized amino acids) was fused to
the total transmembrane domain and intracellular tail of RON (boldface amino acids).
(B-C) TrkA-RON–expressing and empty vector control cells were factor deprived and
restimulated with EPO (5 U/mL; 10 minutes) or NGF (100 ng/mL; 10 minutes), as
indicated. (B) Western blots containing Gab1 and Gab2 immunoprecipitates were
stained with antiphosphotyrosine antibodies and antibodies against Gab1 and Gab2.
Positions of Gab1 and Gab2 are indicated by arrows; positions of size markers are
indicated in kDa. (C) Western blots containing whole-cell lysates were stained for
Tyr694/699–phosphorylated Stat5, Ser473-phosphorylated PKB, and Thr202/Tyr204–
phosphorylated ERK1/2. To control for equal loading, the blot was restained with
anti-Stat5 and anti-ERK1/2.
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partially affected by inhibitors of PI3K or Src kinase, and Gab1
appeared to be recruited by the tyrosine kinase receptor RON. The
observation that EPO-induced Gab1 phosphorylation was absent in
erythroblasts expressing RON lacking the intracellular portion
indicated that RON is absolutely required for EPO-induced Gab1
tyrosine phosphorylation. The partial dependence of Gab1 phosphor-
ylation on PI3K activity suggests that recruitment of Gab1 to RON
can be facilitated by the interaction between the PH domain of
Gab1 with local PIP3. Alternatively, RON may phosphorylate only
part of the Gab1 tyrosines, whereas other tyrosine residues may be
phosphorylated by PI3K-dependent kinases such as Tec and Btk.
We did observe some discrepancies in the interaction between
RON and Gab molecules in erythroblasts and in overexpression
systems. First, the interaction between RON and Gab1 required
RON kinase activity in Y2H experiments, but the interaction
appeared constitutive in erythroblasts. Second, Gab2 was no
substrate for RON on overexpression in COS cells, whereas Gab2
was phosphorylated in response to TrkA-RON activation. To us,
these data represent the intricacy of the EpoR-signaling complex.
RON can interact with Lyn (Figure 4A). In erythroblasts Lyn is
abundantly expressed and present in the EpoR complex. Appar-
ently, Gab2 can be phosphorylated by Lyn, associated with either
the EpoR or RON. RON homologue c-MET also associates with
Src kinases, and its activation similarly induces the phosphoryla-
tion of Gab1 and Gab2.46 In addition, the interaction between RON
and Gab1 may not only depend on interactions between phosphor-
ylated tyrosine residues with the MBS and Grb2, it may be
stabilized by additional scaffolding proteins.
The question arises whether the distinct regulation of EPO-
induced Gab1 and Gab2 is associated with a specific function.
Gab1-deficient mice die at days 14 to 16 of development because of
placental defects.16 At this time the liver is smaller than wt livers.
No obvious erythroid defect can be detected in Gab1/mice, but
the liver defects exclude in vivo assessment of normal adult and
stress erythropoiesis. We observed no difference in the in vitro
expansion and differentiation capacity of erythroblasts derived
from E13 Gab1/fetal livers or in erythroblasts from RON
kinase-deficient mice that did not phosphorylate Gab1 (data not
shown). However, Gab1/ and RON TK/ erythroblasts did
show enhanced EPO-induced tyrosine phosphorylation of Gab2. In
all other cells, Gab proteins can complement each other, resulting
in healthy mice lacking Gab2 and Gab3. Thus, the EpoR appears to
have 2 mechanisms that ensure phosphorylation of either Gab1 or
Gab2 and that may be tuned to ascertain a certain level of signal-
ing activity.
RON is part of the EpoR signaling complex
Although RON can be activated through its ligand (MSP), increas-
ing evidence suggests that RON can also be activated by MSP-
independent mechanisms through heterodimerization. RON has
been shown to interact with various receptors, such as c-Met,
integrins, and the common  chain of the interleukin-5 (IL-5), IL-3,
and granulocyte macrophage–colony-stimulating factor (GM-CSF)
receptor, leading to cross-activation.24,25,47-49 Furthermore, hyal-
uronoglucosaminidase-2 (HYAL2) was found to be a functional
inhibitor of RON. HYAL2 sequestering by the viral envelope
protein of Jaagsiekte sheep retrovirus results in constitutive RON
activity in the absence of ligand.50 In this study, we observed that
MSP did not induce RONfl phosphorylation or downstream
signaling in erythroblasts but that EPO stimulation efficiently
induced RON phosphorylation in the same cells. This occurred in 2
independent cell lines derived from distinct genetic backgrounds
and in erythroblasts expanded from wt fetal livers of either CBA or
129P mice (data not shown). Thus, ligand binding is apparently not
a prerequisite for RON activation in erythroblasts. In addition, on
the overexpression of RONfl in the erythroblast cell line R1,
tyrosine phosphorylation of RON was induced by EPO but not by
MSP (data not shown), suggesting that an inhibitory mechanism
might have been active in these cells, as previously described for
epithelial cells.50
Our data show that Jak2 can phosphorylate RON in COS cells.
The dependence of Gab1 phosphorylation on EPO stimulation in
erythroid cells and on RON kinase activity in COS and erythroid
cells suggests that EPO-induced Jak2 activation not only leads to
phosphorylation of RON but also to its activation. Furthermore, the
Figure 6. TrkA-RON activation can replace EPO in
erythroblast expansion. (A) Erythroblasts undergo re-
newal division in the presence of EPO, SCF, and Dex, but
they differentiate to mature erythroblasts in the presence
of EPO. (B) Empty vector (EV) and TrkA-RON–trans-
duced erythroblasts were seeded in medium containing
no factors (E) or SCF and Dex supplemented with either
EPO (2 U/mL; F) or NGF (10 ng/mL; ). Cells were
counted daily, and cell densities were maintained be-
tween 1.5 and 3  106 cells/mL. Cumulative cell numbers
were calculated. Error bars indicate SD of 3 independent
experiments. (C) Cell morphology in the cultures de-
scribed for panel B was examined on day 6. Cytospins
were stained with histologic dyes and neutral benzidine to
stain hemoglobin and were photographed with 60
magnification. Both cultures contained proliferating blasts
in the presence of EPO/SCF/Dex. In the presence of
NGF/SCF/Dex, control cultures (empty vector) contained
pyknotic cells, whereas TrkA-RON–expressing cultures
contained proliferating blasts. In the absence of factors,
both cultures contained pyknotic cells. (D) TrkA-RON–
expressing cells were factor deprived () and stimulated
with NGF (100 ng/mL) or EPO (5 U/mL). EpoR was
immunoprecipitated from cell lysates and was analyzed
on Western blot with antiphosphotyrosine antibodies or
specific antibodies to check for equal loading.
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data suggest that the EpoR, Jak2, and RON are part of a single
complex because RON is a substrate of Jak2. Although mice
deficient in EPO, EpoR, and the associated kinase Jak2 die at day
13 of gestation because of a lack of erythrocytes, mice in which the
EpoR lacks all tyrosine-docking sites in the EpoR C-terminal tail
develop normally without major aberrations in erythropoiesis.12
Previously it was suggested that signaling intermediates such as
Shc, Shp2, and PI3K could dock to Jak2 on deletion of the
C-terminal tail of EpoR containing the 8 phosphorylated tyrosine
residues. However, because EPO-induced activation of Jak2 results
in RON activation, which subsequently results in the phosphoryla-
tion of Gab1 (directly) and Gab2 (through Src kinases), these
docking molecules may be responsible for recruiting several
signaling intermediates such as Shc, Ship2, and PI3K, indepen-
dently of an intact EpoR C-terminus.
RON is involved in renewal induction
The ability of ligand-activated TrkA-RON to replace EPO stimula-
tion in progenitor expansion, but not differentiation, is in line with
the role of the truncated avian homologue v-SEA, which also
induces the expansion, but not the differentiation, of erythro-
blasts.51 However, though v-SEA expression is sufficient to induce
renewal division in avian erythroblasts, signals emanating from
activated RON in mouse erythroblasts necessitate cooperative
signaling by c-Kit and the glucocorticoid receptor to induce
expansion. Because RON is a downstream target of EpoR signal-
ing, the mechanism of cooperation between NGF, SCF, and Dex
will most likely be similar to cooperative signaling between EPO,
SCF, and Dex, but this remains to be elucidated. TrkA-RON–
expressing erythroblasts exposed to NGF alone rapidly die, indicat-
ing that RON signal transduction through Gab1/2, PI3K, PKB, and
the MAPK route is insufficient for the survival of these cells.
Exogenous (over)expression of a kinase always warrants a careful
interpretation of the results because its regulation may not be
subject to normal controls. However, the fact that activation of
TrkA-RON alone is insufficient for the survival or proliferation of
erythroblasts, but requires cooperation with SCF, suggests that its
function closely mimics that of endogenous RON.
Although RON activation can substitute EpoR activation to
maintain renewal divisions in cooperation with SCF and Dex, it
also transiently sustains renewal division under differentiation
conditions in the presence of EPO. Thus, the EpoR apparently
activates renewal- and differentiation-specific signaling pathways,
which need careful balancing for maintenance of the proper
number of red blood cells. When this balance is disrupted by, for
example, increased RON activity, a polycythemic phenotype may
arise (it occurs in SFFV-infected mice). As shown, EPO induces
several alternative routes to activate common targets, such as PI3K
and MAPK. Thus far it is unclear how these complementary
pathways contribute to EpoR signaling and how cell fate is affected
by change in the balance of these integrated cascades.
Our data are consistent with the observation that RONsf is
required for SFFV to induce erythroleukemia in mice. The gp55
protein targets RONsf,39 resulting in constitutive phosphorylation
and activation of RON and EPO-independent expansion of progeni-
tors. As do the TrkA-RON clones, SFFV-induced erythroleukemia
still requires SCF for renewal induction52 and it permits EPO-
induced differentiation to functional erythrocytes. One of the major
EPO-induced signaling molecules not activated by RON is Stat5.
The inability of ligand-activated TrkA-RON to support in vitro
terminal differentiation of erythroblasts may be attributed to a lack
of Stat5 phosphorylation. Stat5-deficient erythroblasts, cultured in
vitro in serum-free medium, are impaired in EPO-induced differen-
tiation because of the inability to activate the antiapoptotic protein
Bcl-XL.41 Accordingly, mice deficient in Stat5 are impaired in their
response to hypoxia. On hypoxia induction, Stat5-deficient mice
experience anemia accompanied by erythroblast apoptosis.53 Yet
these mice have enlarged spleens and expanded erythroblasts in the
spleen, suggesting impaired differentiation rather than a defect in
expansion. These data suggest that Stat5 activation is essential for
erythroid differentiation but not for expansion. The fact that RON
does not activate Stat5 may be reflected in its inability to induce
differentiation and survival during the onset of differentiation.
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Figure 7. Activation of TrkA-RON fails to support erythroid differentiation and
delays differentiation in the presence of EPO. (A-B) TrkA-RON–expressing
erythroblasts were cultured in medium containing iron-loaded transferrin without
additional factor (NF; E), supplemented with EPO (2 U/mL; F) or with NGF (10
ng/mL; ). Total cell numbers (A) and mean cell volume (B; fl) are depicted. (C) On
day 4 of the experiment, hemoglobin content was measured (Hb/cell volume in
arbitrary units) in empty vector–transduced cultures and TrkA-RON–expressing
cultures seeded in the absence of factor () or in the presence of EPO or NGF. (D-F)
TrkA-RON–expressing erythroblasts were seeded in differentiation medium lacking
growth factor (NF; E) or in medium supplemented with EPO (2 U/mL; F) or EPO (2
U/mL) plus NGF (10 ng/mL; ). Cumulative cell number (D), cell volume (E; fl), and
hemoglobin accumulation (F; Hb/cell volume, in arbitrary units) were determined at
daily intervals. (G) Schematic representation of the results. Empty vector–transduced
cultures and TrkA-RON–expressing cultures could be expanded in the presence of
EPO/SCF/Dex and differentiated in the presence of EPO. When NGF was substituted
for EPO, TrkA-RON–expressing cultures were expanded, whereas control cells
became pyknotic. However, NGF failed to support the differentiation of TrkA-RON–
expressing erythroblasts. In combination with EPO, NGF delayed differentiation of
the TrkA-RON–expressing erythroblasts.
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